skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 

Three things you need to know in the financial markets this morning from investment writer, Tony Cross.

Lloyds Banking Group

Full year results are out from Lloyds Bank [LON:LLOY] this morning – wrapped up in a weighty 112 page document. The critical point for many stock watchers will be the resumption of a dividend payment, although with this coming in at just 0.57p per share, it’s probably lower than many had been hoping for. Regardless, it signals an intention to resume shareholder payouts and sentiment also stands to be bolstered by modest impairment charges in the latter part of the year when compared to the big hit booked in the first half. Underlying profit is reported as being down 71% at just under £2.2 billion.

N4 Pharma

AIM listed biotech N4 Pharma [LON:N4P] has been on the radar in recent months given its work in a novel vaccine delivery system which could benefit the COIVD battle. Full year results have been published today and a sharp increase in R&D costs have served to widen the operating loss to £1.56m, out from the £947k of a year ago. However the company notes its bolstered cash position after successful fundraising last year, with over £3.5m in hand. That gives it more than sufficient capital to complete the current planned works and the expectation is that as the COVID virus evolves, so will vaccines, paving the way for using its technology for their administration. It’s worth adding that the company is also looking at this technology for cancer treatments.


Vodafone [LON:VOD] has confirmed this morning that it plans to list its Vantage Towers division on the Frankfurt stock exchange before the end of March. The offering will consist of a secondary sell-down of shares already held by Vodafone, with the expectation that a meaningful minority free float will facilitate a liquid market for Vantage. How much this is expected to raise – or indeed the planned use of those funds – doesn’t seem to have been identified, but a B2B utility play like that may well be an attractive proposition for investors.

Sign up for three quick facts and more with our Free Daily Digest newsletter, every weekday morning.

Become a better investor with SharePad Designed to give you the confidence to pick your own investments, Sharepad gives you access to a wealth of information on UK, US & European stocks. Find out more

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.


Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
Trade Nation
Back To Top